- Home
- DCO vs BCYC Comparison
DCO vs BCYC Comparison
Compare DCO & BCYC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DCO
- BCYC
- Stock Information
- Founded
- DCO 1849
- BCYC 2009
- Country
- DCO United States
- BCYC United Kingdom
- Employees
- DCO N/A
- BCYC N/A
- Industry
- DCO Military/Government/Technical
- BCYC Biotechnology: Pharmaceutical Preparations
- Sector
- DCO Industrials
- BCYC Health Care
- Exchange
- DCO Nasdaq
- BCYC Nasdaq
- Market Cap
- DCO 1.0B
- BCYC 896.2M
- IPO Year
- DCO N/A
- BCYC 2019
- Fundamental
- Price
- DCO $61.26
- BCYC $11.66
- Analyst Decision
- DCO Strong Buy
- BCYC Buy
- Analyst Count
- DCO 4
- BCYC 9
- Target Price
- DCO $73.50
- BCYC $33.25
- AVG Volume (30 Days)
- DCO 70.4K
- BCYC 275.5K
- Earning Date
- DCO 02-27-2025
- BCYC 02-25-2025
- Dividend Yield
- DCO N/A
- BCYC N/A
- EPS Growth
- DCO 41.24
- BCYC N/A
- EPS
- DCO 2.00
- BCYC N/A
- Revenue
- DCO $781,490,000.00
- BCYC $36,898,000.00
- Revenue This Year
- DCO $4.72
- BCYC $41.07
- Revenue Next Year
- DCO $5.51
- BCYC N/A
- P/E Ratio
- DCO $31.29
- BCYC N/A
- Revenue Growth
- DCO 3.78
- BCYC 48.60
- 52 Week Low
- DCO $47.53
- BCYC $11.14
- 52 Week High
- DCO $70.50
- BCYC $28.67
- Technical
- Relative Strength Index (RSI)
- DCO 29.54
- BCYC 34.58
- Support Level
- DCO $61.95
- BCYC $11.14
- Resistance Level
- DCO $63.27
- BCYC $13.11
- Average True Range (ATR)
- DCO 1.73
- BCYC 0.69
- MACD
- DCO -0.73
- BCYC 0.08
- Stochastic Oscillator
- DCO 9.60
- BCYC 22.32
About DCO Ducommun Incorporated
Ducommun Inc provides engineering & manufacturing services for high-performance products & high-cost-of failure applications used primarily in the aerospace and defense, industrial, medical & other industries. The company's reportable segments are Structural Systems & Electronic Systems. Structural Systems designs, engineers and manufactures various sizes of complex contoured aerostructure components and assemblies and supplies composite and metal bonded structures and assemblies. Electronic Systems designs, engineers and manufactures high-reliability electronic and electromechanical products used in worldwide technology-driven markets including A&D and Industrial end-use markets. It generates maximum of its revenue from the Electronic Systems.
About BCYC Bicycle Therapeutics plc
Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops that stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical needs. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC.